GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes
Y-B Chen(Massachusetts General Hospital), Corey Cutler(Harvard University), Leslie Lehmann(Harvard University), Aleksandr Lazaryan(Moffitt Cancer Center), Álvaro Urbano-Ispizúa(University of St.Gallen), Margaret L. MacMillan(University of Minnesota Medical Center), Ashish Bajel(The Royal Melbourne Hospital), Claire Brady(National Marrow Donor Program), Haydar Frangoul(Children’s Hospital at TriStar Centennial), Rodrigo Martino(Universitat Autònoma de Barcelona), Yoshihiro Inamoto, Medhat Askar(Baylor University Medical Center), Amin M. Alousi(McGill University), Muna Qayed(Emory University), Thomas R. Spitzer(Harvard University), Rachel B. Salit(Johns Hopkins Hospital), Takanori Teshima(Hokkaido University Hospital), T Wang(Medical College of Wisconsin), Shahrukh K. Hashmi(Mayo Clinic), Michael Hemmer(McGill University), Menachem Bitan(Tel Aviv Sourasky Medical Center), Sachiko Seo(National Cancer Center Hospital East), Mukta Arora(Fairview Health Services), Sung Won Choi(University of Michigan), Lolie C. Yu(Louisiana State University), Taiga Nishihori(Moffitt Cancer Center), Stephen R. Spellman(National Marrow Donor Program), Baldeep Wirk(Boston University), Daniel R. Couriel(The University of Texas MD Anderson Cancer Center), Hisham Abdel‐Azim(University of Southern California), Samantha Jaglowski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Richard F. Olsson(AstraZeneca (Netherlands)), Jan Storek(University of Washington), Ran Reshef(Abramson Cancer Center), Bipin N. Savani(Vanderbilt University Medical Center), Ian D. Lewis, M A Kharfan-Dabaja(Moffitt Cancer Center), Gale Rp(Imperial College London), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Joseph Pidala(Moffitt Cancer Center), Mitchell S. Cairo(New York Medical College), D I Marks, Olle Ringdén(Karolinska Institutet)
Cited by 53
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
|New England Journal of Medicine|2011|1.1k